Revitalizing
Healthcare

Roivant is a global biopharmaceutical company focused on reducing the time and cost of the drug development process to improve the lives of patients and their families.

Who We Are

Roivant is dedicated to transformative innovation in healthcare. Our mission is to systematically reduce the time and cost of the drug development process. We partner with innovative biopharmaceutical companies and academic institutions to ensure that important medicines are rapidly delivered to patients. Our goal is to serve our partners, contribute positively to the healthcare system, and improve the lives of patients around the world.

Roivant is the parent of a growing family of companies focused on diverse areas including women’s health, rare diseases, neurology, cardiometabolic diseases, urology, dermatology, RNA therapeutics, and healthcare data analytics.
Learn More About Us

Vivek Ramaswamy on Roivant and how we're different

THE ROIVANT FAMILY OF COMPANIES

Myovant

Dedicated to women’s
health and prostate cancer.

THE ROIVANT FAMILY OF COMPANIES

Enzyvant

Developing transformative therapies
for patients with rare diseases.

THE ROIVANT FAMILY OF COMPANIES

Axovant

Finding new solutions
in neurology.

THE ROIVANT FAMILY OF COMPANIES

Metavant

Looking beyond the current options for cardiometabolic disorders.

THE ROIVANT FAMILY OF COMPANIES

Urovant

Improving quality of life
through advancements in urology.

THE ROIVANT FAMILY OF COMPANIES

Dermavant

Leading innovation in
medical dermatology.

THE ROIVANT FAMILY OF COMPANIES

Genevant

Delivering results through RNA
therapeutics.

THE ROIVANT FAMILY OF COMPANIES

Datavant

Organizing the world's
healthcare data.

THE ROIVANT FAMILY OF COMPANIES

Arbutus

Working towards a cure
for hepatitis B.

OUR WORK

Pipeline

We have a diverse pipeline of 24 investigational drugs in 11 therapeutic areas being tested in over 50 clinical trials and over 300 nonclinical studies across our family of companies.

COMPANY
COMPOUND
INDICATION
PHASE
Company Compound Indication PRECLIN Phase 1 Phase 2 Phase 3
MYOVANT RELUGOLIX

Uterine Fibroids

3

Endometriosis

3

Prostate Cancer

3

MVT-602

Female Infertility

1

ENZYVANT RVT-801

Farber Disease

Preclin

RVT-802

Complete DiGeorge Anomaly

3

AXOVANT NELOTANSERIN

REM Behavior Disorder (RBD) in LBD

2

RVT-104

Alzheimer's Disease and DLB

1

METAVANT IMEGLIMIN

Diabetes

2

RVT-1502

Diabetes

2

UROVANT VIBEGRON

Overactive Bladder

3

DERMAVANT RVT-501

Mild-to-Moderate Atopic Dermatitis

2

RVT-502

Moderate-to-Severe Dermatologic Indications

1

RVT-503

Acne

Preclin

RVT-504

Hyperhidrosis

2

RVT-201

Inflammatory Skin Diseases

1

Arbutus ARB-1467

Hepatitis B

2

AB-506

Hepatitis B

Preclin

AB-452

Hepatitis B

Preclin

AB-729

Hepatitis B

Preclin

OTHER LEFAMULIN

Community-Acquired Bacterial Pneumonia

3

DERAZANTINIB

Intrahepatic Cholangiocarcinoma

2

RVT-701

Autism

2

RVT-702

Undisclosed

Preclin

RVT-1201

Pulmonary Arterial Hypertension

1

RVT-1401

Autoimmune Disorders

1

OUR PEOPLE

Leadership

Our leadership team includes industry veterans as well as exceptional leaders from outside of pharma.

The management teams of our subsidiary companies feature some of the most accomplished executives in the biopharmaceutical industry.

Our directors have deep experience in pharmaceutical business development, academic research, public policy, and life sciences investing.

Members of our Public Stakeholder Advisory Group (PSAG) provide ongoing advice on how Roivant can play a role in improving the healthcare system.

WHO WE WORK WITH

Partners

We work with partners who share our patient-centric commitment to developing new medicines, helping them realize value from potential therapies beyond their core areas of strategic and geographic focus. Select partners are listed below.

STAY INFORMED

News

GET IN TOUCH

Contact Us

Basel, Switzerland
Roivant Sciences GmbH
Viaduktstrasse 8
4051 Basel
Switzerland
New York, NY
Roivant Sciences, Inc.
320 West 37th Street
5th Floor
New York, NY 10018
United States
Durham, NC
Roivant Sciences, Inc.
324 Blackwell Street
Bay 12, Suite 1220
Durham, NC 27701
United States
San Francisco, CA
Myovant Sciences, Inc.
2000 Sierra Point Parkway
9th Floor
Brisbane, CA 94005
United States
Cambridge, MA
Roivant Sciences, Inc.
90 Broadway
Suite 204
Cambridge, MA 02142
United States
Irvine, CA
Urovant Sciences, Inc.
5151 California Avenue
Suite 250
Irvine, CA 92617
United States